» Articles » PMID: 2851053

Why Do Some Drugs Preferentially Block Open Sodium Channels?

Overview
Date 1988 Jun 1
PMID 2851053
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

It has been known for some time now that many antiarrhythmics and local anesthetics block sodium channels especially when they are depolarized. Two major phases of channel blocking occur, one "transient" and one "maintained" during the depolarization. Open channel blocking is thought to occur when intracellular forms of drug access the open channel via an aqueous pathway. This early phase of drug access is transient in the sense that opening of channels occurs for only a brief period of time (a few ms) after a depolarizing stimulus. There is also drug access to the receptor during maintained depolarizations, such as during the plateau phase of cardiac action potentials. New results provided by Kodama et al. regarding these two phases of drug blocking, transient and maintained, have prompted the structural analysis presented here. A surprisingly simple size criterion is developed that explains why certain drugs cannot use the pathway that is available during maintained depolarizations.

Citing Articles

Hydrophobic Drug/Toxin Binding Sites in Voltage-Dependent K and Na Channels.

Van Theemsche K, Van de Sande D, Snyders D, Labro A Front Pharmacol. 2020; 11:735.

PMID: 32499709 PMC: 7243439. DOI: 10.3389/fphar.2020.00735.


Different pH-sensitivity patterns of 30 sodium channel inhibitors suggest chemically different pools along the access pathway.

Lazar A, Lenkey N, Pesti K, Fodor L, Mike A Front Pharmacol. 2015; 6:210.

PMID: 26441665 PMC: 4585259. DOI: 10.3389/fphar.2015.00210.


Scavenging nanoparticles: an emerging treatment for local anesthetic toxicity.

Renehan E, Enneking F, Varshney M, Partch R, Dennis D, Morey T Reg Anesth Pain Med. 2005; 30(4):380-4.

PMID: 16032590 PMC: 3592206. DOI: 10.1016/j.rapm.2005.04.004.


Quaternary ammonium block of mutant Na+ channels lacking inactivation: features of a transition-intermediate mechanism.

Kimbrough J, Gingrich K J Physiol. 2000; 529 Pt 1:93-106.

PMID: 11080254 PMC: 2270171. DOI: 10.1111/j.1469-7793.2000.00093.x.


Increased hindrance on the chiral carbon atom of mexiletine enhances the block of rat skeletal muscle Na+ channels in a model of myotonia induced by ATX.

Desaphy J, Camerino D, Franchini C, Lentini G, Tortorella V, De Luca A Br J Pharmacol. 1999; 128(6):1165-74.

PMID: 10578128 PMC: 1571747. DOI: 10.1038/sj.bjp.0702901.